InvestorsHub Logo
Followers 36
Posts 8838
Boards Moderated 1
Alias Born 07/21/2006

Re: None

Wednesday, 05/08/2024 12:13:05 PM

Wednesday, May 08, 2024 12:13:05 PM

Post# of 43784
Here comes the rain again... " While CEL-SCI may have received positive feedback from the FDA, their small sample size and lack of long-term data raises concerns about the efficacy of Multikine for treating advanced head and neck cancer. Investors should proceed with caution, as there are still many uncertainties surrounding this drug."

The day will come where people ask me "how did you know all this"? I will reply. "Don't ask me that, ask yourself why you did not".

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CVM News